Brief: PeptiDream says entered into technology license agreement with Eli Lilly

PeptiDream

07/03/2016 07:54

March 7 (Reuters) - PeptiDream Inc  4587.T : 
 * Says entered into a technology license agreement with Eli Lilly And Company 
   to nonexclusively license its pdps technology 
 * Says under the terms of the technology license agreement, PeptiDream will 
   receive upfront and annual technology access payments 
 * Says eligible for milestones and royalties on future sales of products from 
   proprietary peptide discovery platform system (pdps) technology 
  
 * Source text for Eikon  ID:nBw5dXXkLa  
 
 * Further company coverage  4587.T  
 ((Bengaluru Newsroom; +1 646 223 8780))